SEARCH

SEARCH BY CITATION

References

  • 1
    Wang Y, Beydoun MA. The obesity epidemic in the United States – gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007; 29: 628
  • 2
    Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 11951200
  • 3
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 16251638
  • 4
    Møller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994; 30A: 344350
  • 5
    Rapp K, Schroeder J, Klenk J et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 2005; 93: 10621067
  • 6
    Wolk A, Gridley G, Svensson M et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001; 12: 1321
  • 7
    Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int 2010; 105: 1620
  • 8
    Siegel EM, Ulrich CM, Poole EM, Holmes RS, Jacobsen PB, Shibata D. The effects of obesity and obesity-related conditions on colorectal cancer prognosis. Cancer Control 2010; 17: 5257
  • 9
    Freedland SJ, Sun L, Kane CJ et al. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU Int 2008; 102: 969974
  • 10
    Dal Maso L, Zucchetto A, Talamini R et al. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 2008; 123: 21882194
  • 11
    Lee CT, Dunn RL, Chen BT, Joshi DP, Sheffield J, Montie JE. Impact of body mass index on radical cystectomy. J Urol 2004; 172: 12811285
  • 12
    Chang SS, Jacobs B, Wells N, Smith JA, Cookson MS. Increased body mass index predicts increased blood loss during radical cystectomy. J Urol 2004; 171: 10771079
  • 13
    Svatek RS, Fisher MB, Williams MB et al. Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy. Urology 2010; 76: 14191424
  • 14
    Hafron J, Mitra N, Dalbagni G, Bochner B, Herr H, Donat SM. Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer? J Urol 2005; 173: 15131517
  • 15
    Novara G, Svatek RS, Karakiewicz PI et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol 2010; 183: 21652170
  • 16
    Shariat SF, Svatek RS, Tilki D et al. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 2010; 105: 14021412
  • 17
    Maurer T, Maurer J, Retz M et al. Influence of body mass index on operability, morbidity and disease outcome following radical cystectomy. Urol Int 2009; 82: 432439
  • 18
    Suikkari AM, Koivisto VA, Rutanen EM, Yki-Järvinen H, Karonen SL, Seppälä M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988; 66: 266272
  • 19
    Iwamura M, Ishibe M, Sluss PM, Cockett AT. Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines. Urol Res 1993; 21: 2732
  • 20
    Shariat SF, Kim J, Nguyen C, Wheeler TM, Lerner SP, Slawin KM. Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer. Urology 2003; 61: 359364
  • 21
    Hilmy M, Campbell R, Bartlett JM, McNicol AM, Underwood MA, McMillan DC. The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer 2006; 95: 12341238
  • 22
    Andrews B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, Lerner SP. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol 2002; 167: 14751481
  • 23
    Butt ZM, Perlmutter AE, Piacente PM et al. Impact of body mass index on robot-assisted radical cystectomy. JSLS 2008; 12: 241245
  • 24
    Herr HW. Surgical factors in the treatment of superficial and invasive bladder cancer. Urol Clin North Am 2005; 32: 157164
  • 25
    Kassouf W, Svatek RS, Shariat SF et al. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol Oncol 2011; Epub ahead of print
  • 26
    Nielsen M, Palapattu G, Karakiewicz P et al. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int 2007; 100: 10151020